Published in Cardiovascular Device Liability Week, February 18th, 2007
The company will now be known as ProSolv CardioVascular, a FUJIFILM Company, and will operate as a wholly owned subsidiary. Combined with Fujifilm's worldwide PACS development headquarters in Stamford, Connecticut, ProSolv's highly sophisticated tools will enable Fujifilm to extend its enterprise information management approach to now include cardiology, and to provide a broader array of integrated technology solutions to a rapidly growing market.
"The need for more tightly integrated enterprise...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.